The earnings call highlighted significant progress in commercialization, particularly in rice herbicide tolerance traits and biofragrance products, alongside notable regulatory advances. However, challenges include a revenue decline and cash runway concerns, with some regulatory delays in the EU. Overall, the call reflects a cautiously optimistic outlook.

Company Guidance

During the Cibus Third Quarter 2025 Results Conference Call, the company provided guidance on several key metrics and strategic initiatives. Cibus reported signing seven rice customer agreements in the USA and Latin America, addressing approximately 5 million to 7 million acres for their HT1 and HT3 rice herbicide tolerance traits, projecting over $200 million in potential annual royalties. These traits are on track for a commercial launch in Latin America in 2027, followed by the U.S. in 2028 and Asia by 2030. The company achieved critical milestones in their biofragrance program, completing pre-commercial pilot runs for two products. Financially, Cibus reported third-quarter revenue of $615,000 and a net loss of $24.3 million, a significant improvement from the prior year's $201.5 million loss. The company has streamlined operations, reducing operating expenses by nearly $5 million in the first nine months of 2025, and aims to reduce annual net cash usage to $30 million by 2026. The call emphasized Cibus's focus on commercialization and strategic partnerships, leveraging regulatory advancements in gene editing to drive future growth.

Expansion of Rice Herbicide Tolerance Traits

Cibus has signed 7 Rice customer agreements in the USA and Latin America, representing approximately 5 million to 7 million addressable acres, with potential annual royalties over $200 million.

Successful Biofragrance Scale-Up

Cibus completed pre-commercial pilot runs for 2 biofragrance products, positioning the company to receive initial payments and expand to full commercial scale in 2026.

Regulatory Approvals and Advancements

The company is seeing positive regulatory developments in the EU, Ecuador, North and South America, India, and parts of Asia, enhancing global market access for gene-edited products.

Cost Reduction and Operational Streamlining

Operating expenses reduced by almost $5 million in the first 9 months of 2025. Consolidation of facilities is on track, aiming for approximately $30 million in annual net cash usage by 2026.

Cibus (CBUS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

CBUS Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Mar 19, 2026	2025 (Q4)	-0.45 / -	-0.87	―	―	―
Nov 13, 2025	2025 (Q3)	-0.44 / -0.44	-7.63	94.23% (+7.19)	―
Aug 14, 2025	2025 (Q2)	-0.60 / -0.61	-1.14	46.49% (+0.53)	―
May 08, 2025	2025 (Q1)	-0.58 / -1.34	-1.12	-19.64% (-0.22)	―
Mar 20, 2025	2024 (Q4)	-0.68 / -0.87	-12.59	93.09% (+11.72)	―
Nov 07, 2024	2024 (Q3)	-0.87 / -7.63	-1.59	-379.87% (-6.04)	―
Aug 08, 2024	2024 (Q2)	-0.81 / -1.14	-3.05	62.62% (+1.91)	―
May 09, 2024	2024 (Q1)	-1.01 / -1.12	-5.45	79.45% (+4.33)	―
Mar 21, 2024	2023 (Q4)	-1.43 / -12.59	-3	-319.67% (-9.59)	―
Nov 09, 2023	2023 (Q3)	-1.17 / -1.59	-6.5	75.54% (+4.91)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

CBUS Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Nov 13, 2025	$1.25	$1.22	-2.40%
Aug 14, 2025	$1.47	$1.41	-4.08%
May 08, 2025	$2.35	$2.14	-8.94%
Mar 20, 2025	$2.19	$2.05	-6.39%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Cibus (CBUS) report earnings?

Cibus (CBUS) is schdueled to report earning on Mar 19, 2026, After Close (Confirmed).

What is Cibus (CBUS) earnings time?

Cibus (CBUS) earnings time is at Mar 19, 2026, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is CBUS EPS forecast?

CBUS EPS forecast for the fiscal quarter 2025 (Q4) is -0.45.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing